Psychedelics: A new frontier in mental health treatment
Recent studies suggest that psychedelics may aid in the treatment of mental and neurological disorders. It appears that these substances enhance the brain's neuroplasticity and have a positive impact on the treatment of anxiety and post-traumatic stress disorder. Could we be buying LSD or psilocybin at the pharmacy in the future?
Psychedelics can have therapeutic effects, but only under certain conditions. In recent years, a growing number of studies indicate that these substances can support the treatment of depression, PTSD, anxiety, and addictions, particularly when combined with psychotherapy.
A new approach to therapy
Researchers from the University of Michigan have discovered that a single administration of psychedelics significantly improves the brain's cognitive functions. The results of these studies may greatly influence psychiatry and modern therapeutic methods, potentially offering support to patients with various conditions, including those not helped by traditional medications.
The findings could revolutionise psychiatry by providing new therapeutic methods for patients who have not been aided by conventional pharmacology. The first research on psychedelics commenced as early as the 1950s, sparking considerable interest among scientists. Substances such as LSD and psilocybin were analysed for their potential application in treating depression, alcoholism, anxiety, and as an adjunct in psychotherapy. Many of these early studies yielded promising results, with patients reporting significant changes in self-perception and a reduction in psychological symptoms. Despite these positive outcomes, the substances began to be used outside scientific control, resulting in widespread use of psychoactive substances and strong political and social backlash, which ultimately led to their prohibition.
The journal "Psychedelics" published studies demonstrating that mice given a single dose of 25CN-NBOH achieved better results in tasks related to learning reversal compared to control group animals. Notably, these positive effects were visible even two to three weeks after the substance was administered.
Long-term benefits
Cellular analyses confirm that psychedelics alter the structure of the prefrontal cortex, leading to improved brain function. Researchers emphasise that the benefits may persist long after the direct effects of the drug have worn off.
The research provides evidence of the therapeutic effects of psychedelics and could represent a step forward in treating treatment-resistant conditions. Therapies utilising these substances may produce effects enduring for several months.
